Food News and Research

RSS

FDA takes action against unapproved single-ingredient oral colchicine

The U.S. Food and Drug Administration took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF).

1 Oct 2010

DMC recommends continuation of enrollment in Celsion's Phase III ThermoDox HEAT study for primary liver cancer

Celsion Corporation, a leading oncology drug development company, announced that after reviewing data from 401 patients enrolled in its pivotal Phase III ThermoDox ® clinical study (the HEAT study) for primary liver cancer, the Data Monitoring Committee (DMC) has unanimously recommended that the trial continue to enroll patients with the goal of reaching the 600 patients required to complete the study.

1 Oct 2010

World Bank President calls for new, more open approach to economic development

"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).

1 Oct 2010

New processing technology uses low-energy electron beams to decontaminate food

A collaborative agreement between CSIRO and two German organisations is providing Australian food companies with access to a new processing technology which uses low-energy electron beams rather than heat or chemicals to decontaminate food.

1 Oct 2010

School vending machines can influence students' dietary choices

With over 23 million children and adolescents in the US overweight or obese, the risks for many chronic diseases continue to increase. An article in the October issue of the Journal of the American Dietetic Association examines the diets of American youth and finds some disturbing results.

1 Oct 2010

APhA urges consumers to discuss proper medication usage with pharmacists

In honor of American Pharmacists Month, the American Pharmacists Association (APhA) encourages consumers to hold an open dialogue with their pharmacists about a growing problem in the United States, the proper usage of and adherence to medications.

1 Oct 2010

Food labeling urged to be more stringent

After recent research from campaigning organization Greenpeace found the S-26 Soy brand of infant formula contains GM or genetically modified ingredients that are not disclosed on the product label, two Senators are urging the Federal Government to tighten Australia's food labeling laws.

30 Sep 2010

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

Wenzel Spine, Inc., a medical device company focused on offering less invasive, stand-alone alternatives to traditional spinal fusion, today announced they have received 510K clearance to market the VariLift Expandable Interbody Fusion System.

30 Sep 2010

Natural remedy for eczema

Eczema Free Forever provides answers with practical, homemade and natural solutions, that the eczema suffering population in any part of the world can easily perform in the comfort of their home.

30 Sep 2010

Walt Disney launches national initiative to raise healthy, happy kids

The Walt Disney Company today launched Disney Magic of Healthy Living - a national multimedia initiative designed to partner with parents in their quest to raise healthy, happy kids. The initiative, which includes public service announcements featuring First Lady Michelle Obama and young Disney stars, builds on the Company's commitment to a healthier generation of kids begun in 2006 with the announcement of landmark nutritional guidelines associating Disney brands and characters with a more nutritionally balanced range of foods.

30 Sep 2010

ICM, University of Warsaw partner with AAAS to provide site-wide access to Science publication

Washington, D.C. and Warsaw, Poland: The Interdisciplinary Centre for Mathematical and Computational Modelling (ICM), University of Warsaw, has partnered with the American Association for the Advancement of Science (AAAS) in a national site licensing agreement to provide 922 research and scientific institutions throughout Poland with site-wide access to Science , the flagship publication of AAAS.

30 Sep 2010

Universitat Jaume I evaluates ruthenium compounds for neurodegenerative disease treatment

The pharmaceutical division of the company Neuron BPh and the research group of Organometallic Chemistry and Homogeneous Catalysis of the Universitat Jaume I, have evaluated the possible applications of a series of ruthenium compounds for their future use in the treatment of neurodegenerative disease such as Alzheimer.

30 Sep 2010

Teva Pharmaceuticals, OncoGenex initiate SYNERGY Phase 3 trial to evaluate custirsen

Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).

30 Sep 2010

Children with eczema at greater risk of developing asthma and food allergies

Children with eczema, a chronic skin condition that often begins in childhood, have a greater risk of developing asthma and food allergies. The number of children with eczema is rising, but the reasons for this are unclear. A new study soon to be published in The Journal of Pediatrics examines the relationship between pet ownership and eczema. Researchers found that dog ownership among children with dog allergies may reduce the risk of developing eczema by age 4 years; cat ownership, however, may increase the risk among children with cat allergies.

30 Sep 2010

Long-term high protein diet has negative effects on body mass, hormones and genes

A high protein diet during development primes the body to react unhealthily to future food binges. A study on juvenile rats, published in BioMed Central's open access journal Nutrition and Metabolism, suggests that lasting changes result from altering the composition of the first solid food that is consumed throughout growth into early adulthood.

30 Sep 2010

Genotoxic impurities in prescription drugs

Drug manufacturers have been adjusting to strict new government standards that limit the amount of potentially harmful impurities in medicine, according to the cover story of the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. The impurities are "genotoxic," capable of damaging the DNA in genes.

30 Sep 2010

Dyax, CMIC enter agreement to develop and commercialize DX-88 for HAE treatment

Dyax Corp. and CMIC Co., Ltd, announced today an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema (HAE) and other angioedema indications in Japan.

30 Sep 2010

Researchers explain why obesity is resistant to treatment

New research provides evidence of the vicious cycle created when an obese individual overeats to compensate for reduced pleasure from food.Obese individuals have fewer pleasure receptors and overeat to compensate, according to a study by University of Texas at Austin senior research fellow and Oregon Research Institute senior scientist Eric Stice and his colleagues published this week in The Journal of Neuroscience.

30 Sep 2010

Obama administration officials discuss global development policy at roundtable event

President Barack Obama's top cabinet members stressed Tuesday that devoting money and resources to overseas diplomacy and development is essential to U.S. national security, CNN reports.

30 Sep 2010

New form of immunotherapy increases survival in children with neuroblastoma

Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions. The percentage rose from 46 percent for children receiving a standard therapy to 66 percent for children receiving immunotherapy plus standard therapy, according to the study published in the Sept. 30, 2010 issue of the New England Journal of Medicine.

30 Sep 2010